337 related articles for article (PubMed ID: 29196555)
1. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
Yan C; Theodorescu D
Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
[TBL] [Abstract][Full Text] [Related]
2. Drugging the Ral GTPase.
Yan C; Jones DN; Theodorescu D
Small GTPases; 2015; 6(3):157-9. PubMed ID: 26280620
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of small molecules that target the GTPase Ral.
Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
[TBL] [Abstract][Full Text] [Related]
4. The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Guin S; Theodorescu D
Acta Pharmacol Sin; 2015 Mar; 36(3):291-7. PubMed ID: 25557115
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
7. Targeting Ras signaling in AML: RALB is a small GTPase with big potential.
Pomeroy EJ; Eckfeldt CE
Small GTPases; 2020 Jan; 11(1):39-44. PubMed ID: 28682649
[TBL] [Abstract][Full Text] [Related]
8. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
9. Ral GTPases: crucial mediators of exocytosis and tumourigenesis.
Shirakawa R; Horiuchi H
J Biochem; 2015 May; 157(5):285-99. PubMed ID: 25796063
[TBL] [Abstract][Full Text] [Related]
10. The RAL signaling network: Cancer and beyond.
Apken LH; Oeckinghaus A
Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
[TBL] [Abstract][Full Text] [Related]
11. Small molecules inhibit the RAS-like small GTPases RALA and RALB.
Cancer Discov; 2014 Nov; 4(11):1251. PubMed ID: 25367937
[TBL] [Abstract][Full Text] [Related]
12. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
13. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
[TBL] [Abstract][Full Text] [Related]
14. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
Cooper JM; Bodemann BO; White MA
Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
[TBL] [Abstract][Full Text] [Related]
15. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
Cells; 2022 May; 11(10):. PubMed ID: 35626682
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases.
Bum-Erdene K; Liu D; Gonzalez-Gutierrez G; Ghozayel MK; Xu D; Meroueh SO
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7131-7139. PubMed ID: 32179690
[TBL] [Abstract][Full Text] [Related]
17. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.
Gentry LR; Nishimura A; Cox AD; Martin TD; Tsygankov D; Nishida M; Elston TC; Der CJ
J Biol Chem; 2015 Sep; 290(37):22851-61. PubMed ID: 26216878
[TBL] [Abstract][Full Text] [Related]
18. The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.
Neel NF; Martin TD; Stratford JK; Zand TP; Reiner DJ; Der CJ
Genes Cancer; 2011 Mar; 2(3):275-87. PubMed ID: 21779498
[TBL] [Abstract][Full Text] [Related]
19. RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS.
Seibold M; Stühmer T; Kremer N; Mottok A; Scholz CJ; Schlosser A; Leich E; Holzgrabe U; Brünnert D; Barrio S; Kortüm MK; Solimando AG; Chatterjee M; Einsele H; Rosenwald A; Bargou RC; Steinbrunn T
Haematologica; 2020 Sep; 105(9):2316-2326. PubMed ID: 33054056
[TBL] [Abstract][Full Text] [Related]
20. Ral signaling pathway in health and cancer.
Moghadam AR; Patrad E; Tafsiri E; Peng W; Fangman B; Pluard TJ; Accurso A; Salacz M; Shah K; Ricke B; Bi D; Kimura K; Graves L; Najad MK; Dolatkhah R; Sanaat Z; Yazdi M; Tavakolinia N; Mazani M; Amani M; Ghavami S; Gartell R; Reilly C; Naima Z; Esfandyari T; Farassati F
Cancer Med; 2017 Dec; 6(12):2998-3013. PubMed ID: 29047224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]